PSNL (Personalis) Total Equity: $254.77 Mil (As of Mar. 2026)


PSNL Personalis Inc PSNL
59 GF Score
Price $11.18
GF Value $2.07
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Personalis Total Equity?

Personalis PSNL +11.13% 59 Total Equity is $254.77 Mil as of Mar. 2026. GuruFocus rates PSNL with a GF Score™ of 59/100 and a GF Value™ of $2.07 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Personalis's total equity for the quarter that ended in Mar. 2026 was $254.77 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Personalis Total Equity Historical Data

* Premium members only.

The historical data trend for Personalis's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Personalis Total Equity Chart

Personalis Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only 310.30 218.14 129.44 202.96 261.19

Personalis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 207.35 190.83 171.42 261.19 254.77
PSNL
59GF Score
Personalis Inc PSNL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Personalis Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Personalis's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=334.164-72.979
=261.19

Personalis's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=325.395-70.63
=254.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $254.77 Mil mean?
Personalis (PSNL) has a Total Equity of $254.77 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Personalis and its competitors.
Is Personalis' Total Equity too high?
Personalis' current Total Equity is $254.77 Mil. Overall, Personalis has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Personalis' Total Equity compare to CDNA and OPK?
Personalis' Total Equity of $254.77 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Personalis and its competitors. Personalis's current Total Equity is $254.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Personalis stock overvalued right now?
Based on GuruFocus' analysis, Personalis (PSNL) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.07, compared to a current price of $11.18 — trading 440.1% above its estimated fair value. The current Total Equity is $254.77 Mil. Personalis' overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Personalis (PSNL), the current Total Equity is $254.77 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Personalis (PSNL) Overvalued in 2026?

Based on GuruFocus' analysis, Personalis stock appears to be overvalued. The current stock price of $11.18 is trading 440.1% above its estimated GF Value™ of $2.07. GuruFocus considers Personalis to be Significantly Overvalued.

Key valuation signals for PSNL:

  • Total Equity: $254.77 Mil
  • GF Value™: $2.07 vs. price of $11.18 (440.1% above fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the PSNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Personalis Business Description

Other Exchanges 04X:Germany
Address 6600 Dumbarton Circle, Fremont, CA, USA, 94555
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
59GF Score

Get the complete analysis for PSNL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.18
Price
$2.07
GF Value